nodes	percent_of_prediction	percent_of_DWPC	metapath
Finasteride—Drostanolone—SHBG—gestational diabetes	0.191	0.229	CrCbGaD
Finasteride—Drostanolone—AR—gestational diabetes	0.167	0.201	CrCbGaD
Finasteride—Drostanolone—CYP19A1—gestational diabetes	0.14	0.168	CrCbGaD
Finasteride—Testosterone Propionate—AR—gestational diabetes	0.102	0.123	CrCbGaD
Finasteride—Progesterone—SHBG—gestational diabetes	0.0533	0.0642	CrCbGaD
Finasteride—Testosterone—SHBG—gestational diabetes	0.0504	0.0607	CrCbGaD
Finasteride—Progesterone—AR—gestational diabetes	0.0468	0.0563	CrCbGaD
Finasteride—Testosterone—AR—gestational diabetes	0.0442	0.0532	CrCbGaD
Finasteride—Testosterone—CYP19A1—gestational diabetes	0.037	0.0445	CrCbGaD
Finasteride—SRD5A1—Metabolism of steroid hormones and vitamin D—CYP19A1—gestational diabetes	0.0329	0.195	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of steroid hormones and vitamin D—CYP19A1—gestational diabetes	0.0329	0.195	CbGpPWpGaD
Finasteride—AKR1D1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00773	0.0458	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—GGCT—gestational diabetes	0.00477	0.0282	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GGCT—gestational diabetes	0.00432	0.0256	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GGCT—gestational diabetes	0.00432	0.0256	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GGCT—gestational diabetes	0.00385	0.0228	CbGpPWpGaD
Finasteride—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00385	0.0228	CbGpPWpGaD
Finasteride—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.0038	0.0225	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GLS2—gestational diabetes	0.00378	0.0224	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GLS2—gestational diabetes	0.00378	0.0224	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—GGCT—gestational diabetes	0.00345	0.0204	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00338	0.02	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00338	0.02	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GLS2—gestational diabetes	0.00337	0.0199	CbGpPWpGaD
Finasteride—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00312	0.0185	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	0.00301	0.0178	CbGpPWpGaD
Finasteride—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00278	0.0165	CbGpPWpGaD
Finasteride—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00275	0.0163	CbGpPWpGaD
Finasteride—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00226	0.0134	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—NAMPT—gestational diabetes	0.00207	0.0123	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—NAMPT—gestational diabetes	0.00207	0.0123	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—GCK—gestational diabetes	0.00206	0.0122	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—GCK—gestational diabetes	0.00206	0.0122	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—NAMPT—gestational diabetes	0.00185	0.0109	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—GCK—gestational diabetes	0.00183	0.0109	CbGpPWpGaD
Finasteride—CYP3A7—Biological oxidations—CYP19A1—gestational diabetes	0.00166	0.00983	CbGpPWpGaD
Finasteride—CYP3A7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00164	0.00969	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.0016	0.00949	CbGpPWpGaD
Finasteride—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.0016	0.00948	CbGpPWpGaD
Finasteride—SRD5A2—Metabolism—CYP19A1—gestational diabetes	0.0015	0.00891	CbGpPWpGaD
Finasteride—SRD5A1—Metabolism—CYP19A1—gestational diabetes	0.0015	0.00891	CbGpPWpGaD
Finasteride—AKR1D1—Metabolism—CYP19A1—gestational diabetes	0.00134	0.00794	CbGpPWpGaD
Finasteride—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00129	0.00767	CbGpPWpGaD
Finasteride—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00128	0.00757	CbGpPWpGaD
Finasteride—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	0.0012	0.0071	CbGpPWpGaD
Finasteride—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00118	0.007	CbGpPWpGaD
Finasteride—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00105	0.00622	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GGCT—gestational diabetes	0.000815	0.00483	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GLS2—gestational diabetes	0.000712	0.00422	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GGCT—gestational diabetes	0.000589	0.00349	CbGpPWpGaD
Finasteride—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000557	0.0033	CbGpPWpGaD
Finasteride—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.00055	0.00326	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GLS2—gestational diabetes	0.000515	0.00305	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—NAMPT—gestational diabetes	0.00039	0.00231	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—GCK—gestational diabetes	0.000388	0.0023	CbGpPWpGaD
Finasteride—CYP3A7—Metabolism—CYP19A1—gestational diabetes	0.000284	0.00168	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—NAMPT—gestational diabetes	0.000282	0.00167	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—GCK—gestational diabetes	0.00028	0.00166	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GGCT—gestational diabetes	0.000274	0.00162	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GLS2—gestational diabetes	0.000239	0.00142	CbGpPWpGaD
Finasteride—CYP3A5—Metabolism—CYP19A1—gestational diabetes	0.000205	0.00121	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—NAMPT—gestational diabetes	0.000131	0.000777	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—GCK—gestational diabetes	0.00013	0.000772	CbGpPWpGaD
Finasteride—CYP3A4—Metabolism—CYP19A1—gestational diabetes	9.53e-05	0.000565	CbGpPWpGaD
